Ultrasonic stimulation of the ear's vagus nerve in healthy adults
Official title: UltraSONIC Vagus Nerve Stimulation: Investigation U-VNS Effects on Physiological, Emotional and Cognitive Biomarkers
Run by University of Nottingham · NCT07283913 · Data updated 2026-11-12
This will test whether placing a painless ultrasound device on the ear can stimulate the vagus nerve in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Nottingham Academic / other |
| Locations | 2 sites (Nottingham, Nottinghamshire and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | May 2026 |
| Study ends | May 2026 |
| Registry record updated | December 16, 2025 |
| Trial ID | NCT07283913 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18 or older who are not taking medications (except contraceptives), have no major neurological, psychiatric, cardiac, or metabolic disorders, and can follow study requirements like fasting and removing left-ear piercings.
✕Probably not a fit
People with diabetes, significant heart conditions or arrhythmias, high blood pressure, recent use of nervous-system–active drugs, or those seeking treatment for an existing medical condition are unlikely to benefit from participating in this healthy-volunteer protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will deliver non-invasive focused ultrasound to the auricular branch of the vagus nerve in healthy volunteers to see if this activates parasympathetic responses. Participants attend multiple visits with requirements such as removing left-ear piercings and fasting beforehand, while investigators record physiological and metabolic signals. The approach aims to provide a non-electrical alternative to implanted or transcutaneous electrical VNS, reducing risks associated with surgery or skin electrodes. Measurements likely include heart rate, breathing or other autonomic markers and metabolic signals such as glucose to determine acute effects of the stimulation.
Why it matters
Potential benefit: If successful, this could offer a non-invasive way to modulate the vagus nerve that might lead to safer, easier treatments for conditions currently treated with electrical or implanted VNS.
How similar studies have gone: Electrical and transcutaneous auricular VNS have shown therapeutic effects for epilepsy and some neuropsychiatric conditions, but ultrasonic auricular VNS in humans is novel with limited prior human data and mixed results for some indications.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Participant is willing and able to give informed consent for participation in the study * Not currently taking any medications (except the contraceptive pill) * Aged 18 or over * Good general health * Able and willing to remove any piercings in the left ear * Able to abstain from exercise and fast from food for 12 hours before the second and third visit Exclusion Criteria * Current or past diagnosis of a major neurological, neurosurgical, or psychiatric disorder (including self-reported depression) * Inability to complete informed consent process * Personal history of cardiac arrhythmia * Diabetes * High blood pressure (\>140 mmHg systolic and/or \>90 mmHg diastolic) * Other significant medical condition (including cardiological disorders; specific details to be reviewed by the CI prior to inclusion) * Use of medication or recreational drugs that affect the nervous system in the past 3 months * Medication intake (such as beta-blockers, glucocorticoids, antidepressants, anti-inflammatory drugs) in the last 7 days - contraceptive medication in women is allowed * Currently pregnant or breastfeeding * Allergy to aquasonic gel or any of its components (propylene glycol, glycerin, isothiazolinones) * Participation in a research study in the last 3 months involving invasive procedures or an inconvenience allowance (required for all UoN FMHS UREC-approved studies) * BMI \< 18 kg/m² or \> 30 kg/m² * Excessive consumption of alcohol (\>2 alcoholic beverages/day) or tobacco (\>5 cigarettes/day) * Previous experience with stress tests * Known infection in the last 8 weeks
Where it's running
-
Neuromodulation Lab, Medical School, Queen's Medical Centre
Nottingham, Nottinghamshire, United Kingdom Recruiting -
University of Nottingham
Nottingham, United Kingdom Not yet recruiting
Study contacts
- Principal investigator: Marcus Kaiser, Professor — University of Nottingham
- Study coordinator: Alicia Falcon-Caro, PhD
- Email: Alicia.falconcaro@nottingham.ac.uk
- Phone: +44 7502043643
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.